Analysis of mechanisms and frequency of CDKN2A/B gene loss during progression of RAS-transformed rat embryo fibroblast clones

Somatic Cell and Molecular Genetics

Volumn 24, Issue 6, 1998, Pages 327-339

  Zhou, Jian Nian ^a   Hashemi, Jamileh ^a   Helou, Khalil ^b   Zhang, Anju ^a   Röhme, Dan ^b   Zetterberg, Anders ^a   Levan, Göran ^b   Linder, Stig ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Box 462   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; DEXAMETHASONE; DNA; GLUCOCORTICOID;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; DNA SEQUENCE; EMBRYO; FIBROBLAST; GENE DELETION; GENE EXPRESSION; GENETIC MARKER; HETEROZYGOSITY LOSS; HORMONE ACTION; KARYOTYPE; NONHUMAN; ONCOGENE; ONCOGENE RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT;

ANIMALIA; RODENTIA;

EID: 0032470603     PISSN: 07407750     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024486307061     Document Type: Article

References (34)

1. Cavenee, W.K., Dryja, T.P., Phillips, R.A., Benedict, W.F., Godbout, R., Gallie, B.L., Murphree, A.L., Strong, L.C., and White, R.L. (1983). Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305:779-784.
2. Gupta, P.K., Sahota, A., Boyadjiev, S.A., Bye, S., Shao, C., O'Neill, P., Hunter, T.C., Albertini, R.J., Stambrook, P.J., and Tischfield, J.A. (1997). High frequency in vivo loss of heterozygocity is primarily a consequence of mitotic recombination. Cancer Res. 57:1188-1193.
3. Liggett, W.H.J., and Sidransky, D. (1998). Role of the p16 tumor suppressor gene in cancer. J. Clin. Onc. 16:1197-1206.
4. Levine, A.J., Wu, M.C., Chang, A., Silver, A., Attiyeh, E.F., Lin, J., and Epstein, C.B. (1995). The spectrum of mutations at the p53 locus. Evidence for tissue-specific mutagenesis, selection of mutant alleles, and a "gain of function" phenotype. Ann. N. Y. Acad. Sci. 768:111-128.
5. Funaki, K., Everitt, J., Oshimura, M., Freed, J.J., Knudson, A.G.J., and Walker, C. (1991). Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6. Cancer Res. 51:4415-4422.
6. Levan, G., Hedrich, H.J., Remmers, E.F., Serikawa, T., and Yoshida, M.C. (1995). Standardized rat genomic nomenclature. Mammalian Genome 6:447-448.
7. Gollahon, L.S., Chen, A., and Aldaz, C.M. (1995). Loss of heterozygosity at chromosome 1q loci in rat mammary tumors. Molecular Carcinogenesis 12: 7-13.
8. Hegi, M.E., Devereux, T.R., Dietrich, W.F., Cochran, C.J., Lander, E.S., and Foley, J.F. (1994). Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Research 54:6257-6264.
9. Szpirer, C., Riviere, M., Szpirer, J., Genet, M., Dreze, P., Islam, M.Q., and Levan, G. (1990). Assignment of 12 loci to rat chromosome 5: evidence that this chromosome is homologous to mouse chromosome 4 and to human chromosomes 9 and 1 (p arm). Genomics 6:679-684.
10. Jacob, H.J., Brown, D.M., Bunker, R.K., Daly, M.J., Dzau, V.J., Goodman, A., Koike, G., Kren, V., Kurtz, T., Lernmark, A., Levan, G., Mao, Y-P., Pettersson, A., Pravenec, M., Simon, J.S., Szpirer, C., Szpirer, J., Trolliet, M.R., Winer, E.S., and Lander, E.S. (1995). A genetic linkage map of the laboratory rat, Rattus norvegicus. Nature Genetics 9:63-69.
11. Spandidos, D.A., and Wilkie, N. (1984). Malignant transformation of early passage rodent cells by a single mutated human oncogene. Nature 310:469-475.
12. Pozzatti, R., Muschel, R., Williams, J., Padmanabhan, R., Howard, B., Liotta, L., and Khoury, G. (1986). Primary embryo cells transformed by one or two oncogenes show different metastatic potentials. Science 232:223-227.
13. Martens, I., Nilsson, M., Magnusson, G., and Linder, S. (1988). Glucocorticoids facilitate the stable transformation of embryonal rat fibroblasts by a polyomavirus large tumor antigen deficient mutant. Proc. Natl. Acad. Sci. U.S.A. 85:5571-5575.
14. Yamashita, T., Kato, H., and Fujinaga, K. (1988). Conditional immortalization and/or transformation of rat cells carrying v-abl or EJras oncogene in the presence or absence of glucocorticoid hormone. Int. J. Cancer 42:930-938.
15. Muschel, R.J., Nakahara, K., Chu, E., Pozzatti, R., and Liotta, L.A. (1986). Karyotypic analysis of diploid or near diploid metastatic Harvey ras transformed rat embryo fibroblasts. Cancer Res. 46:4104-4108.
16. Zhou, J.N., Ljungdahl, S., Röhme, D., Levan, G., Shoshan, M.C., and Linder, S. (1997). Codeletion of the JUN proto-oncogene and the CDKN2A tumor-suppressor gene in HRAS-transformed rat embryo fibroblast cell lines. Genes, Chromosomes & Cancer 20:82-89.
17. Serrano, M., Lee, H.W., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R.A. (1996). Role of the INK4A locus in tumor suppression and cell mortality. Cell 85:27-37.
18. Kamijo, T., Zindy, F, Roussel, M.F., Quelle, D.E., Downing, J.R., Ashmun, R.A., Grosveld, G., and Sherr, C.J. (1997). Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649-659.
19. Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., and Lowe, S.W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
20. Kiyono, T., Foster, S.A., Koop, J.I., McDougall, J.K., Galloway, D.A., and Klingelhutz, A.J. (1998). Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84-88.
21. Marshall, H., Popowicz, P., Engel, G., Martens, I., and Linder, S. (1993). Lack of c-jun expression in a transformed cell line isolated by glucocorticoid promotion of ras-transfected rat embryo fibroblasts. Oncogene 8:1303-1309.
22. Islam, M.Q., and Levan, G. (1987). A new fixation procedure for improved quality G-bands in routine cytogenetic work. Hededitas 107:127-130.
23. Carter, N.P., Ferguson-Smith, M.A., Perryman, M.T., Telenius, H., Pelmear, A.H., Leversha, M.A., Glancy, M.T., Wood, S.L., Cook, K., Dyson, H.M., et al. (1992). Reverse chromosome painting: a method for the rapid analysis of aberrant chromosomes in clinical cytogenetics. J. Med. Gen. 29:299-307.
24. Quelle, D.E., Ashmun, R.A., Hannon, G.J., Rehberger, P.A., Trono, D., Richter, K.H., Walker, C., Beach, D., Sherr, C.J., and Serrano, M. (1995). Cloning and characterization of murine p16INK4a and p15INK4b genes. Oncogene 11:635-645.
25. Ercolani, L., Florence, B., Denaro, M., and Alexander, M. (1988). Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 263:15335-15341.
26. Helou, K., Lü, X.C., Montelius-Alatalo, K., Levan, G., and Röhme, D. A dual-color FISH framework map of rat chromosome 5q23-36 and characterization of a deletion-inversion related to tumor suppression in a rat/mouse hepatoma cell hybrid. Manuscript. (In press.)
27. Foulds, L. (1975). Neoplastic Development. Academic Press, New York.
28. Li, C.Y., Yandell, D.W., and Little, J.B. (1992). Molecular mechanisms of spontaneous and induced loss of heterozygosity in human cells in vitro. Som. Cell & Mol. Gen. 18:77-87.
29. Jonat, C., Rahmsdorf, H.J., Park, K-K., Cato, A.C.B., Gebel, S., Ponta, H., and Herrlich, P. (1990). Antitumor promotion and antiinflammation: downmodulation of AP-1 (fos/jun) activity by glucocoiticoid hormone. Cell 62:1189-1204.
30. Harwood, J., Tachibana, A., Davis, R., Bhattacharyya, N.P., and Meuth, M. (1993). High rate of multilocus deletion in a human tumor cell line. Human Mol. Gen. 2:165-171.
31. de Jong, P.J., Grosovski, A.J., and Glickman, B.W. (1988). Spectrum of spontaneous mutation at the APRT locus of Chinese hamster ovary cells: an analysis at the DNA sequence level. Proc. Natl. Acad. Sci. U.S.A. 85:3499-3503.
32. Noble, J.R., Rogan, E.M., Neumann, A.A., Maclean, K., Bryan, T.M., and Reddel, R.R. (1996). Association of extended in vitro proliferative potential with loss of p16INK4 expression. Oncogene 13:1259-1268.
33. Blasco, M.A., Lee, H.W., Hande, M.P., Samper, E., Lansdorp, P.M., DePinho, R.A., and Greider, C.W. (1997). Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91:25-34.
34. Kipling, D. (1997). Telomere structure and telomerase expression during mouse development and tumorigenesis. Eur. J. Cancer 33:792-800.